IMS Company Profiles - Report Buyer

IMS Company Profiles - Report Buyer IMS Company Profiles - Report Buyer

reportbuyer.com
from reportbuyer.com More from this publisher
03.01.2013 Views

IMS COM PANY PRO FILES TAKEDA Financial Data Key Figures Share Data: Shares are quoted on the Lon don, Osaka, To kyo, Nagoya, Fukuoka, Hi ro shima, Sapporo and Niigata Stock Ex changes. Key Fig ures: Key Fig ures (Con sol i dated) for years end ing March 31: Unit: Yen bil lions, ex cept EPS in Yen 2008 2007 2006 2005 2004 Sales 1,374.8 1,305.2 1,212.2 1,123.0 1,086.4 R&D 275.8 193.3 169.6 141.5 129.7 Pre-tax Profit 576.8 625.4 518.0 441.1 446.1 Net Profit 355.5 335.8 313.2 277.4 285.3 Earnings per Share (Yen) 419.0 386.0 353.5 313.01 321.9 Current Assets 2243.8 2,357.7 2,372.0 1,969.9 1,730.1 Fixed Assets 605.5 714.8 670.3 575.5 605.5 Total Assets 2,849.3 3,072.5 3,042.3 2,545.4 2,335.7 Total Liabilities 526.7 611.4 646.7 499.2 512.2 Shareholders’ Equity 2,314.2 2,216.7 2348.4 2,001.4 1,781.0 Source: Takeda An nual Re ports Sales by Business Sector for years ending March 31: Unit: Yen bil lions 2008 2007 2006 2005 2004 Pharmaceuticals 1,272.1 1,202.8 1,074.5 970.5 935.3 Other* 102.7 102.4 137.7 152.5 151.1 TOTAL 1,374.8 1,305.2 1,212.2 1,123.4 1,086.4 Source: Takeda An nual Re ports *Note: Seg ment clas si fi ca tions were re vised dur ing FY2003, the re sults of which were ret ro ac tively re - stated. © 2009 IMS Health In cor po rated or its af fil i ates Page 80

IMS COM PANY PRO FILES TAKEDA Sales by Geographical Region for years ending March 31: Unit: Yen bil lions 2008 2007 2006 2005 2004 Japan 859.3 661.7 675.1 644.5 624.5 North America 357.9 426.6 335.9 287.4 296.0 Europe 147.3 192.0 180.2 171.6 147.3 Asia/Other Markets 10.3 25.0 21.0 19.4 18.6 TOTAL 1,374.8 1,305.2 1,212.2 1,123.4 1,086.4 Source: Takeda An nual Re ports © 2009 IMS Health In cor po rated or its af fil i ates Page 81

<strong>IMS</strong> COM PANY PRO FILES TAKEDA<br />

Financial Data<br />

Key Figures<br />

Share Data: Shares are quoted on the Lon don, Osaka, To kyo, Nagoya, Fukuoka, Hi ro shima, Sapporo<br />

and Niigata Stock Ex changes.<br />

Key Fig ures: Key Fig ures (Con sol i dated) for years end ing March 31:<br />

Unit: Yen bil lions, ex cept EPS in Yen<br />

2008 2007 2006 2005 2004<br />

Sales 1,374.8 1,305.2 1,212.2 1,123.0 1,086.4<br />

R&D 275.8 193.3 169.6 141.5 129.7<br />

Pre-tax Profit 576.8 625.4 518.0 441.1 446.1<br />

Net Profit 355.5 335.8 313.2 277.4 285.3<br />

Earnings per Share (Yen) 419.0 386.0 353.5 313.01 321.9<br />

Current Assets 2243.8 2,357.7 2,372.0 1,969.9 1,730.1<br />

Fixed Assets 605.5 714.8 670.3 575.5 605.5<br />

Total Assets 2,849.3 3,072.5 3,042.3 2,545.4 2,335.7<br />

Total Liabilities 526.7 611.4 646.7 499.2 512.2<br />

Shareholders’ Equity 2,314.2 2,216.7 2348.4 2,001.4 1,781.0<br />

Source: Takeda An nual Re ports<br />

Sales by Business Sector for years ending March 31:<br />

Unit: Yen bil lions<br />

2008 2007 2006 2005 2004<br />

Pharmaceuticals 1,272.1 1,202.8 1,074.5 970.5 935.3<br />

Other* 102.7 102.4 137.7 152.5 151.1<br />

TOTAL 1,374.8 1,305.2 1,212.2 1,123.4 1,086.4<br />

Source: Takeda An nual Re ports<br />

*Note: Seg ment clas si fi ca tions were re vised dur ing FY2003, the re sults of which were ret ro ac tively re -<br />

stated.<br />

© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 80

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!